(106 days)
Not Found
No
The device description and performance studies focus on the mechanical and electrical properties of a manual surgical instrument, with no mention of AI or ML algorithms for data processing, analysis, or decision-making.
No
The device is described as a "manual surgical instrument" used to "clear secretions and test surgical tissue with nerve stimulation." Its function is diagnostic/monitoring (nerve stimulation) and surgical assistance (suction), not to treat or cure a disease or condition.
No
This device is described as a surgical instrument that allows for clearing secretions and "test[ing] surgical tissue with nerve stimulation." While it performs a "test," the intent is to stimulate nerves and clear secretions during surgery, not to diagnose a condition or disease. The product's intended use is as a manual surgical instrument for operational procedures rather than for diagnosis.
No
The device is a physical surgical instrument with a stainless steel shaft, insulation, ball-tip suction, and connectors, clearly indicating it is a hardware device, not software-only.
Based on the provided information, this device is not an IVD (In Vitro Diagnostic).
Here's why:
- IVD Definition: In Vitro Diagnostics are medical devices used to examine specimens taken from the human body (like blood, urine, tissue) to provide information about a person's health. This information is used for diagnosis, monitoring, or screening.
- Device Function: The Suction Stimulator Probe is a surgical instrument used during surgery to clear secretions and stimulate nerves in vivo (within the living body). It directly interacts with the patient's tissues.
- Intended Use: The intended use clearly states it's a "manual surgical instrument" for use "during surgery" to "clear secretions and test surgical tissue with nerve stimulation." This is a surgical procedure, not an in vitro diagnostic test.
- Device Description: The description details a physical instrument with a shaft, tip, and connectors for suction and stimulation. It does not describe a device that analyzes biological samples.
Therefore, the Suction Stimulator Probe falls under the category of a surgical instrument used for therapeutic and diagnostic purposes during a surgical procedure, not an in vitro diagnostic device.
N/A
Intended Use / Indications for Use
The Suction Stimulator Probe is a dedicated manual surgical instrument that allows the surgeon to clear secretions and test surgical tissue with nerve stimulation at the same time and with the same instrument. It is intended for use only by a licensed physician and in conjunction with the Neurovision SE (Nerveäna) Nerve locator Monitor System.
Product codes (comma separated list FDA assigned to the subject device)
ETN
Device Description
The Suction Stimulator Probe is a disposable, single use, sterile instrument that combines concurrent suction and stimulation into one device for use during tissue dissection and nerve stimulation during surgery.
The instrument consists of a stainless steel shaft, partially insulated with biocompatible PTFE and ending with a ball-tip suction. Proximal connectors attach the instrument to a nerve stimulator. A tapered type adapter attaches the device to a standard suction catheter and a finger-hole allows for adjusting the suction strength manually by the surgeon. The insulated shaft has a 2mm diameter and 2 length options of 13 or 26 cm. The ball tip feature reduces the current density of stimulation, allows stimulation along right angles, such as drill holes, and prevents bone chip clogging of the instrument.
Mentions image processing
Not Found
Mentions AI, DNN, or ML
Not Found
Input Imaging Modality
Not Found
Anatomical Site
Not Found
Indicated Patient Age Range
Not Found
Intended User / Care Setting
licensed physician
Description of the training set, sample size, data source, and annotation protocol
Not Found
Description of the test set, sample size, data source, and annotation protocol
Not Found
Summary of Performance Studies (study type, sample size, AUC, MRMC, standalone performance, key results)
Bench testing to assess performance and safety included micrometer measurement of the ball tip diameter, electrical continuity testing, and suction testing with applied air. These testing criteria were selected to test the quality of the manufacturing, the reliability of the surface area of the ball as indicating the current density of delivered stimulation, the continuity of the device as reflecting the reliability of current delivered to the tip, and finally, the gross delivery of air/suction as reflecting the suction power of the device.
Key Metrics (Sensitivity, Specificity, PPV, NPV, etc.)
Not Found
Predicate Device(s): If the device was cleared using the 510(k) pathway, identify the Predicate Device(s) K/DEN number used to claim substantial equivalence and list them here in a comma separated list exactly as they appear in the text. List the primary predicate first in the list.
Reference Device(s): Identify the Reference Device(s) K/DEN number and list them here in a comma separated list exactly as they appear in the text.
Not Found
Predetermined Change Control Plan (PCCP) - All Relevant Information for the subject device only (e.g. presence / absence, what scope was granted / cleared under the PCCP, any restrictions, etc).
Not Found
§ 874.1820 Surgical nerve stimulator/locator.
(a)
Identification. A surgical nerve stimulator/locator is a device that is intended to provide electrical stimulation to the body to locate and identify nerves and to test their excitability.(b)
Classification. Class II.
0
K 110712
P. 1 of 2
Image /page/0/Picture/1 description: The image shows the logo for Neurovision Medical. The word "neurovision" is in large, bold, black letters. Underneath the word is a line with a heartbeat symbol in the middle, and the word "MEDICAL" is in smaller, bold, black letters to the right of the line.
Traditional 510k - Suction Stimulator Probe
JUN 2 8 2011
5. 510K Summary
In accordance with Title 21 of the Code of Federal Regulations, Part 807 and in particular 21 CFR §807.92, the following summary of information is provided:
Applicant Information
Christine Vergelv Regulatory Affairs Manager Neurovision Medical Products, Inc. 2225 Sperry Ave., Suite 1000 Ventura, CA 93003 PH 805-866-6999 Fax: 413-410-4579 christie@neurovisionmedical.com
| Date of Summary | June 28, 2011 |
|---|---|
| ----------------- | --------------- |
| Device Identification | Trade Name: DryTouch Suction Stimulator Probe
Common Name: Suction Stimulator Probe |
|-----------------------|----------------------------------------------------------------------------------------------------------------------------|
| Classification | Class II
Number 874.1820, Nerve Stimulator / Locator
Product code: ETN |
| Predicate Devices | Manufacturer: Elmed Inc.
Device Name: Frazier Suction Coagulator (part #23-5001)
510k Number: Pre-amendment device |
| | Manufacturer: Neurovision Medical Products Inc.
Device Name: Hemostat/Stimulator Probe (SHEM-s)
510K Number: K895676 |
| | Manufacturer: Axon Systems, Inc.
Device Name: XPAK II
510K Number: K090838 |
Device Description
The Suction Stimulator Probe is a disposable, single use, sterile instrument that combines concurrent suction and stimulation into one device for use during tissue dissection and nerve stimulation during surgery.
The instrument consists of a stainless steel shaft, partially insulated with biocompatible PTFE and ending with a ball-tip suction. Proximal connectors attach the instrument to a nerve stimulator. A tapered type adapter attaches the device to a standard suction catheter and a finger-hole allows for adjusting the suction strength manually by the surgeon. The insulated shaft has a 2mm diameter and 2 length options of 13 or 26 cm. The ball tip feature reduces the current density of stimulation, allows stimulation along right angles, such as drill holes, and prevents bone chip clogging of the instrument.
1
K110712
P. 2 of 2
Image /page/1/Picture/1 description: The image shows the logo for Neurovision Medical. The word "neurovision" is in large, bold, black letters. Underneath the word "neurovision" are three horizontal lines, followed by a graphic of a heartbeat, and then the word "MEDICAL" in smaller, black letters.
Traditional 510k - Suction Stimulator Probe
Intended Use
The Suction Stimulator Probe is a dedicated manual surgical instrument that allows the surgeon to clear secretions and test surgical tissue with nerve stimulation at the same time and with the same instrument. It is intended for use only by a licensed physician and in conjunction with the Neurovision SE (Nerveäna) Nerve locator Monitor System.
Technological Characteristics of Device in Relation to Predicate Devices
The Suction Stimulator Probe combines technology from several predicate devices: the Frazier Suction Coagulator (part #23-5001), the Hemostat/Stimulator Probe (SHEM-s) K895676, and the XPAX II Nerve Stimulation Probe (K090838).
-
The Suction Stimulator Probe is substantially equivalent to the Frazier Suction Coagulator with an extended shaft length: the body of the Suction Stimulator Probe is a Frazier Suction Coagulator with its shaft extended from 17.7cm to 26 cm or shortened to 13 cm.
-
The Suction Stimulator Probe's stimulating capability is substantially equivalent to the stimulating capability of the Hemostat/Stimulator Probe (SHEM-s) K895676: the device is coated with PTFE insulating material and a dedicated wire is added for connection to an approved nerve stimulator.
-
The Suction Stimulator probe is substantially equivalent to the Axon Systems XPAK II (K090838) in that both are stimulating, dissecting instruments with biocompatible electrical insulation, which attach to a nerve stimulator for nerve stimulation during surgery.
Assessment of Performance Data Used to Justify Substantial Equivalence
Bench testing to assess performance and safety included micrometer measurement of the ball tip diameter, electrical continuity testing, and suction testing with applied air. These testing criteria were selected to test the quality of the manufacturing, the reliability of the surface area of the ball as indicating the current density of delivered stimulation, the continuity of the device as reflecting the reliability of current delivered to the tip, and finally, the gross delivery of air/suction as reflecting the suction power of the device.
Sterilization:
- EO validation is compliant with ISO 11135-1.2007. ●
- EO residuals analysis is compliant with ISO 10993-7:2008. .
- The Sterility Assurance Level is 10-6. .
- . Device is not labeled non-pyrogenic.
Shelf Life Testing:
- Shelf life is 1 year and was confirmed by package integrity testing compliant with ISO 11607. .
2
DEPARTMENT OF HEALTH & HUMAN SERVICES
Image /page/2/Picture/1 description: The image shows the logo for the U.S. Department of Health & Human Services. The logo consists of a circular seal with the text "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA" around the perimeter. Inside the circle is an abstract symbol that resembles an eagle or bird in flight.
Food and Drug Administration 10903 New Hampshire Avenue Document Control Room -WO66-G609 Silver Spring. MD 20993-0002
Neurovision Medical Products, Inc. c/o Ms. Christine Vergely Regulatory Manager 2225 Sperry Avenue, Suite 1000 Ventura, CA 93003
JUN 2 8 2011
Re: K110712
Trade/Device Name: DryTouch Suction Stimulator Probe Regulation Number: 21 CFR 874.1820 Regulation Name: Surgical Nerve Stimulator/Locator Regulatory Class: Class II Product Code: ETN Dated: May 22, 2011 Received: May 24, 2011
Dear Ms. Vergely:
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting (reporting of medical
3
Page 2 - Ms. Christine Vergely
device-related adverse events) (21 CFR 803); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.
If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please go to http://www.fda.gov/AboutFDA/CentersOffices/CDRH/CDRHOffices/ucm115809.htm for the Center for Devices and Radiological Health's (CDRH's) Office of Compliance. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to
http://www.fda.gov/MedicalDevices/Safety/ReportalProblem/default.htm for the CDRH's Office of Surveillance and Biometrics/Division of Postmarket Surveillance.
You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (301) 796-7100 or at its Internet address http://www.fda.gov/MedicalDevices/Resourcesfor You/Industry/default.htm.
Sincerely yours.
Melvin R. Fahlman, Ph.D.
Malvina B. Eydelman, M.D. Director Division of Ophthalmic, Neurological, and Ear, Nose and Throat Devices Office of Device Evaluation Center for Devices and Radiological Health
Enclosure
4
Image /page/4/Picture/0 description: The image shows the logo for Neurovision Medical. The word "neurovision" is in bold, black letters on the top line. Underneath the word is a line with a graphic and the word "MEDICAL" in smaller, black letters. The text "Traditional 510k - Suction Stimulator Probe" is at the bottom of the image.
Indications for Use
510(k): K110712
Device Name: Suction Stimulator Probe
Statement of Indications for Use for the Suction Stimulator Probe:
The Suction Stimulator Probe is a dedicated manual surgical instrument that allows the surgeon to clear secretions and test surgical tissue with nerve stimulation at the same time and with the same instrument. It is intended for use only by a licensed physician and in conjunction with the Neurovision SE (Nerveana) Nerve locator Monitor System.
Prescription Use X (Part 21 CFR 801 Subpart D)
AND/OR
Over-The-Counter Use (21 CFR 801 Subpart C)
(PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE IF NEEDED)
Aper Douch
(Division SignsOff) urrence of CDRH, Office of Device Evaluation (ODE) Division of Ophthalmic, Neurological Nose and Throat Devices
Prescription Use
(Per 21 CFR 801.109)
510(k) Number K110712